DrugPatentWatch Database Preview
RUBRACA Drug Profile
Which patents cover Rubraca, and when can generic versions of Rubraca launch?
Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. There are ten patents protecting this drug.
The generic ingredient in RUBRACA is rucaparib camsylate. One supplier is listed for this compound. Additional details are available on the rucaparib camsylate profile page.
Summary for RUBRACA
| US Patents: | 10 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 11 |
| Clinical Trials: | 1 |
| Patent Applications: | 41 |
| Drug Prices: | Drug price information for RUBRACA |
| DailyMed Link: | RUBRACA at DailyMed |
Generic Entry Opportunity Date for RUBRACA
Generic Entry Date for RUBRACA*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for RUBRACA
| Drug Class | Poly(ADP-Ribose) Polymerase Inhibitor |
| Mechanism of Action | Poly(ADP-Ribose) Polymerase Inhibitors |
Synonyms for RUBRACA
| 283173-50-2 |
| 6-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-3,10-DIAZATRICYCLO[6.4.1.0?,(1)(3)]TRIDECA-1,4(13),5,7-TETRAEN-9-ONE |
| 6H-Azepino(5,4,3-cd)indol-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- |
| 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- |
| 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- |
| 8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON |
| 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one |
| 8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one |
| 8-FLUORO-2-(4-((METHYLAMINO)METHYL)PHENYL)-4,5-DIHYDRO-1H-AZEPINO[5,4,3-CD]INDOL-6(3H)-ONE |
| 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one |
| 8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one |
| 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one |
| 8237F3U7EH |
| AC-24390 |
| AG 014699 |
| AG-14447 |
| AG14447 |
| AK317822 |
| AKOS015898427 |
| BDBM50446130 |
| BRD-K88560311-011-01-4 |
| CHEBI:134689 |
| CHEBI:94311 |
| CHEMBL1173055 |
| CS-2785 |
| CTK4G1217 |
| D01SHZ |
| D10079 |
| DB12332 |
| DTXSID10182563 |
| FT-0696622 |
| GTPL7736 |
| HMABYWSNWIZPAG-UHFFFAOYSA-N |
| HY-10617A |
| I10-0690 |
| KB-73984 |
| Kinome_3180 |
| MolPort-028-744-762 |
| NCGC00263173-01 |
| NCGC00263173-03 |
| PF 01367338 |
| PF01367338 |
| PL006099 |
| RPB |
| Rubraca (TN) |
| RUCAPARIB |
| Rucaparib (free base) |
| Rucaparib (USAN/INN) |
| Rucaparib [USAN:INN] |
| Rucaparib(AG-014447) |
| SCHEMBL844585 |
| Tube725 |
| UNII-8237F3U7EH |
| Z-3241 |
| ZINC25958 |
US Patents and Regulatory Information for RUBRACA
International Patents for RUBRACA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Taiwan | I338000 | ➤ Try a Free Trial |
| Serbia | 55487 | ➤ Try a Free Trial |
| Singapore | 11201700265V | ➤ Try a Free Trial |
| Australia | 2011213944 | ➤ Try a Free Trial |
| Luxembourg | 92680 | ➤ Try a Free Trial |
| Norway | 335959 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for RUBRACA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 3 50005-2015 | Slovakia | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB; REGISTRATION NO/DATE: EU/1/14/959 20141218 |
| 2015016 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIBUM; REGISTRATION NO/DATE: EU/1/14/959 20141216 |
| 00726 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB, EN ZOUTEN EN; REGISTRATION NO/DATE: EU/1/14/959/001 20141216 |
| 500012 | Hungary | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB |
| 15/016 | Ireland | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB, AND SALTS AND SOLVATES THEREOF; REGISTRATION NO/DATE: EU/1/14/959/001 20141216 |
| 2015016,C1633724 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIBAS IR JO DRUSKOS IR SOLVATAI; REGISTRATION NO/DATE: EU/1/14/959 20141216 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
